Hiroki Mizuno

807 total citations
106 papers, 454 citations indexed

About

Hiroki Mizuno is a scholar working on Nephrology, Molecular Biology and Rheumatology. According to data from OpenAlex, Hiroki Mizuno has authored 106 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Nephrology, 29 papers in Molecular Biology and 29 papers in Rheumatology. Recurrent topics in Hiroki Mizuno's work include Renal Diseases and Glomerulopathies (39 papers), Genetic and Kidney Cyst Diseases (18 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers). Hiroki Mizuno is often cited by papers focused on Renal Diseases and Glomerulopathies (39 papers), Genetic and Kidney Cyst Diseases (18 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers). Hiroki Mizuno collaborates with scholars based in Japan, United States and South Korea. Hiroki Mizuno's co-authors include Naoki Sawa, Yoshifumi Ubara, Masayuki Yamanouchi, Tatsuya Suwabe, Junichi Hoshino, Akinari Sekine, Eiko Hasegawa, Kenichi Ohashi, Noriko Hayami and Kenmei Takaichi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroki Mizuno

91 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Mizuno Japan 11 152 118 94 91 74 106 454
Anissa Moktefi France 13 191 1.3× 51 0.4× 90 1.0× 109 1.2× 75 1.0× 46 493
L.H. Noël France 10 164 1.1× 58 0.5× 180 1.9× 71 0.8× 91 1.2× 16 452
Michael Borofsky United States 8 206 1.4× 119 1.0× 48 0.5× 36 0.4× 171 2.3× 15 447
Mikako Warren United States 12 88 0.6× 90 0.8× 136 1.4× 112 1.2× 83 1.1× 47 668
Soo Min Ahn South Korea 12 59 0.4× 83 0.7× 113 1.2× 67 0.7× 160 2.2× 64 423
M Nakano Japan 14 125 0.8× 94 0.8× 129 1.4× 128 1.4× 255 3.4× 49 649
Lindi Jiang China 14 135 0.9× 128 1.1× 172 1.8× 185 2.0× 113 1.5× 22 638
Chadi Saifan United States 13 48 0.3× 87 0.7× 64 0.7× 40 0.4× 258 3.5× 30 536
Dongbao Zhao China 11 42 0.3× 49 0.4× 113 1.2× 81 0.9× 116 1.6× 26 390
Kristell Desseaux France 11 57 0.4× 74 0.6× 112 1.2× 145 1.6× 50 0.7× 18 414

Countries citing papers authored by Hiroki Mizuno

Since Specialization
Citations

This map shows the geographic impact of Hiroki Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Mizuno more than expected).

Fields of papers citing papers by Hiroki Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Mizuno. The network helps show where Hiroki Mizuno may publish in the future.

Co-authorship network of co-authors of Hiroki Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Mizuno. A scholar is included among the top collaborators of Hiroki Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Mizuno. Hiroki Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oba, Yuki, Hiroki Mizuno, Akinari Sekine, et al.. (2025). Sarcoidosis Induced by Metal Particles From a Left Elbow Prosthesis. Kidney Medicine. 7(9). 101066–101066.
2.
Lee, Hwa‐Young, Etsuji Suzuki, Hiroki Mizuno, et al.. (2025). Global Incidence Trend of Early-Onset Obesity-Related and Non-Obesity-Related Cancers. Current Oncology. 32(6). 324–324.
3.
Yoshimura, Yusuke, Hiroki Mizuno, Keiichi Kinowaki, et al.. (2024). Efficacy of SGLT2 inhibitors in IgA nephropathy associated with alcoholic liver cirrhosis accompanied by nephrotic syndrome: a case report. SHILAP Revista de lepidopterología. 3. 1331757–1331757. 1 indexed citations
4.
Sekine, Akinari, Tatsuya Suwabe, Junichi Hoshino, et al.. (2024). Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver Disease. Internal Medicine. 63(21). 2965–2970. 1 indexed citations
5.
Yoshimura, Yusuke, Tatsuya Suwabe, Takayoshi Yokoyama, et al.. (2024). Renal cell carcinoma preceded by a rheumatoid‑like paraneoplastic syndrome: A case report. Oncology Letters. 28(4). 448–448. 1 indexed citations
6.
Yoshimura, Yusuke, Masayuki Yamanouchi, Hiroki Mizuno, et al.. (2024). Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease. Annals of the Rheumatic Diseases. 83(10). 1278–1287. 3 indexed citations
7.
Suwabe, Tatsuya, Yuki Oba, Hiroki Mizuno, et al.. (2023). A Half-Century Dialysis Survivor: Clinical and Autopsy Findings. Kidney Medicine. 5(4). 100612–100612. 3 indexed citations
8.
Suwabe, Tatsuya, Yoshifumi Ubara, Yuki Oba, et al.. (2023). Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation. SHILAP Revista de lepidopterología. 7(1). 69–80. 1 indexed citations
9.
Sawa, Naoki, Hiroki Mizuno, Yuki Oba, et al.. (2023). Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination. Internal Medicine. 62(14). 2139–2143. 3 indexed citations
10.
Suwabe, Tatsuya, Yoshifumi Ubara, Yuki Oba, et al.. (2023). Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease. Journal of Nephrology. 36(4). 999–1010. 3 indexed citations
11.
Yamanouchi, Masayuki, Naoki Sawa, Tadashi Toyama, et al.. (2023). Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease. Kidney International Reports. 9(2). 323–333. 4 indexed citations
12.
TERAZAWA, Yuki, et al.. (2022). NUMERICAL INVESTIGATION OF DYNAMIC RESPONSE CHARACTERISTIC OF DAMPED BRACED TUBE SYSTEM WITH DIFFERENT DAMPED SLIT COMFIGURATION. Journal of Structural and Construction Engineering (Transactions of AIJ). 87(802). 1247–1256. 2 indexed citations
13.
Sekine, Akinari, Takuya Fujimaru, Tatsuya Suwabe, et al.. (2021). Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease. SHILAP Revista de lepidopterología. 8(3). 246–252. 5 indexed citations
14.
Sawa, Naoki, Masayuki Yamanouchi, Akinari Sekine, et al.. (2021). Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis. Clinical and Experimental Nephrology. 26(4). 341–349. 7 indexed citations
15.
Sawa, Naoki, Hideomi Fujiwara, Masayuki Yamanouchi, et al.. (2020). Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis. SHILAP Revista de lepidopterología. 4(6). 815–820. 1 indexed citations
16.
Hiramatsu, Rikako, Junichi Hoshino, Hiroki Mizuno, et al.. (2020). Denosumab for dialysis patients with osteoporosis: A cohort study. Scientific Reports. 10(1). 2496–2496. 36 indexed citations
17.
Mizuno, Hiroki, Naoki Sawa, Shun Watanabe, et al.. (2020). The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome. Kidney International Reports. 5(8). 1172–1179. 21 indexed citations
18.
Ôshima, Yôichi, Keiichi Sumida, Masayuki Yamanouchi, et al.. (2020). Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders. Scientific Reports. 10(1). 1490–1490. 5 indexed citations
19.
20.
Sumida, Keiichi, Hiroki Mizuno, Toshiharu Ueno, et al.. (2018). Lupus nephritis with massive subendothelial deposits in a patient with autoimmune hepatitis-related cirrhosis. Human Pathology Case Reports. 13. 27–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anissa Moktefi Breakdown of academic impact, for papers by L.H. Noël Breakdown of academic impact, for papers by Michael Borofsky Breakdown of academic impact, for papers by Mikako Warren Breakdown of academic impact, for papers by Soo Min Ahn Breakdown of academic impact, for papers by M Nakano Breakdown of academic impact, for papers by Lindi Jiang Breakdown of academic impact, for papers by Chadi Saifan Breakdown of academic impact, for papers by Dongbao Zhao Breakdown of academic impact, for papers by Kristell Desseaux
Rankless by CCL
2026